CRISPR Therapeutics AG (CRSP) Goodwill & Intangibles (2015 - 2024)

CRISPR Therapeutics AG has disclosed Goodwill & Intangibles across 10 years of filings, most recently posting $2000.0 for Q1 2024.

• In Q1 2024, Goodwill & Intangibles fell 96.49% year-over-year to $2000.0; the TTM figure through Mar 2024 stood at $2000.0 (down 96.49% YoY), while the FY2023 annual figure was $16000.0, down 77.46% from the prior year.
• Goodwill & Intangibles came in at $2000.0 for Q1 2024 at CRISPR Therapeutics AG, down from $16000.0 in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $221000.0 in Q1 2020 to a low of $2000.0 in Q1 2024.
• Average Goodwill & Intangibles over 5 years is $111764.7, with a median of $112000.0 recorded in 2022.
• Year-over-year, Goodwill & Intangibles slipped 19.93% in 2020 and plunged 96.49% in 2024.
• Over 5 years, Goodwill & Intangibles stood at $180000.0 in 2020, then plunged by 30.56% to $125000.0 in 2021, then sank by 43.2% to $71000.0 in 2022, then plunged by 77.46% to $16000.0 in 2023, then sank by 87.5% to $2000.0 in 2024.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $2000.0 in Q1 2024, $16000.0 in Q4 2023, and $30000.0 in Q3 2023.